CompletedNCT06309472
Mirtazapine study for depression with inflammatory bowel disease
About this title
Read the official source — NCT06309472Medication studyAges 18–125United Kingdom
Understand this study
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 125 years. Other eligibility criteria applied.
What did participation involve?
The protocol includes: Completing questionnaires. Providing blood samples.
- Listed locations
- London and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: May 7, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 76
- Sponsor
- King's College London
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United Kingdom
- Age range
- From 18 Years to 125 Years
- Official registry ID
- NCT06309472
- Official title
Show the full official title
A Multi-centre, Double-blind Randomised Controlled Trial to Compare Mirtazapine Versus Placebo Over 12 Weeks in Patients With Multimorbid Major Depression and Inflammatory Bowel Disease (MD-IBD): a Feasibility Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
London
Interested in joining this study?
Questions about this study
What did participation involve?
The protocol called for participants to provide blood samples.
Who is behind this study?
The study sponsor is King's College London, a university.
Did this study involve medication?
Yes. The study involved medication, including Mirtazapine and Placebo.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 125 years. Other eligibility criteria applied.
